NEREUS PHARMACEUTICALS
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.
NEREUS PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
1998-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.nereuspharm.com
Total Employee:
11+
Status:
Active
Contact:
19999999999
Email Addresses:
[email protected]
Total Funding:
139.8 M USD
Technology used in webpage:
SPF Microsoft Exchange Online GoDaddy Network Solutions DNS
Similar Organizations
Capulus Therapeutics
Capulus Therapeutics engages in drug discovery and development with a predictive AI guided approach to target the root cause of diseases.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Multiple Myeloma Research Foundation
The MMRF relentlessly pursues innovative means that accelerate the development of next-generation multiple myeloma treatments to extend
NAEJA-RGM Pharmaceuticals
NAEJA-RGM Pharmaceuticals engages in proprietary drug discovery work and is a player in the field of infectious disease research.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pacific Venture Group
Pacific Venture Group investment in Series E - Nereus Pharmaceuticals
Forward Ventures
Forward Ventures investment in Series E - Nereus Pharmaceuticals
Alta Partners
Alta Partners investment in Series E - Nereus Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series E - Nereus Pharmaceuticals
Astellas Venture Management
Astellas Venture Management investment in Series E - Nereus Pharmaceuticals
Roche Venture Fund
Roche Venture Fund investment in Series E - Nereus Pharmaceuticals
Advent International
Advent International investment in Series E - Nereus Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Nereus Pharmaceuticals
Roche Venture Fund
Roche Venture Fund investment in Series D - Nereus Pharmaceuticals
Astellas Venture Management
Astellas Venture Management investment in Series D - Nereus Pharmaceuticals
Official Site Inspections
http://www.nereuspharm.com
- Host name: 98.220.74.97.host.secureserver.net
- IP address: 97.74.220.98
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Nereus Pharmaceuticals"
Nereus Pharmaceuticals - Wikipedia
Until 2004, Nereus used methods licensed from the University of California, San Diego to retrieve and cultivate marine microorganisms, particularly bacteria in the Actinomycetia class and organisms belonging to Kingdom Fungi. Since 2004, the company has focused on commercializing identified bioactive natural products. As of mid-2007, two compounds were being examined in Phase I clinical trials: NPI-2358 and NPI-0052. See details»
Nereus Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, …See details»
Nereus Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 10480 Wateridge Circle . San Diego, California, 92121, United States. 858-587-4090See details»
Nereus Pharmaceuticals - Ownership and Business Overview
Jan 2, 2012 Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012.The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was …See details»
Nereus Pharma 2025 Company Profile: Valuation, Funding
Nereus Pharma General Information Description. Developer of innovative pharmaceutical products designed for the aquaculture industry. The company's products include a new …See details»
Nereus Pharmaceuticals - Overview, News & Similar companies
Who is Nereus Pharmaceuticals. Nereus Pharmaceuticals pursues novel sources of chemical diversity to discover and develop new therapeutics. Using its unmatched expertise in marin e …See details»
Nereus Pharmaceuticals | F6S
Similar companies Reneo Pharmaceuticals Pyxis Oncology Naurex Merus Retex Pharmaceuticals We develop revolutionary medicines Neuron23 Cerulean Pharmaceutical Develops …See details»
Nereus Pharmaceuticals Inc. Information
View Nereus Pharmaceuticals Inc. contact information in addition to a brief company description provided by CareersInPharmaceutical.comSee details»
Nereus Pharmaceuticals - VentureRadar
Sunesis has built an experienced drug development organization committed to improving the lives of people with cancer. QAtor Denmark Privately Held QAtor is a global software firm …See details»
Nereus Pharmaceuticals, Inc.:Company Profile & Technical …
Nereus Pharmaceuticals, Inc. is a company that provides Solid tumor, Inflammation, Proteasome inhibitor and more. Nereus Pharmaceuticals, Inc. is headquartered in United States California.See details»
Nereus Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Nereus Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 66 literature, Drug:NPI-3304, NPI-3114, NPI ...See details»
Nereus Pharmaceuticals - LinkedIn
Nereus Pharmaceuticals | 252 followers on LinkedIn. ... Ganda Business Solutions Ltd. Business Consulting and Services Basel, BSSee details»
Nereus Pharmaceuticals - Golden
A company developing biologically active compounds and drug candidates. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Nereus Pharma - Crunchbase Company Profile & Funding
Nereus Pharma creates novel pharmacological medicines for the aquaculture industry with the goal of increasing aquaculture health.See details»
Nextsource | Company Profile | Nereus Pharmaceuticals
Explore the company profile of Nereus Pharmaceuticals (nereuspharm.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D
Aug 9, 2007 Contacts: Kobi M. Sethna, President & CEO Nereus Pharmaceuticals, Inc. (858) 587-4093 [email protected] Pam Lord Porter Novelli Life Sciences for Nereus (619) …See details»
Nereus Pharmaceuticals Completes Enrollment of Phase 2 …
SAN DIEGO, June 22 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery and development from marine microbial sources, announced completion of enrollment in the …See details»
Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non ...
Mar 20, 2008 Upon successful completion of the Phase 1b trial and determination of the recommended doses for the combined agents, Nereus expects to advance NPI-2358 into an …See details»
Nereus Pharmaceuticals Completes Enrollment of Phase 2 …
Jun 23, 2010 Nereus' second drug candidate, marizomib (NPI-0052), is a second-generation inhibitor of the 20S proteasome. Marizomib also continues to progress in a number of clinical …See details»
PRESS RELEASE: Nereus Pharmaceuticals Raises $45 ... - Fierce …
Aug 9, 2007 Nereus Pharmaceuticals Raises $45 Million in Series D-2 Financing SAN DIEGO, Aug. 9 -- Nereus Pharmaceuticals, Inc., a pioneer in the use of marine microbial sources forSee details»